Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic Blood or Marrow Transplantation for Hematologic Malignancy and Aplastic Anemia

NCT00003816 is registered in ClinicalTrials.gov with Roswell Park Cancer Institute as lead sponsor.

NCT NCT00003816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic Blood or Marrow Transplantation for Hematologic Malignancy and Aplastic Anemia
Lead sponsor
Roswell Park Cancer Institute
Phase
Phase 2/3
Overall status
Completed
Start date
October 19, 1998
Completion date
July 12, 2019
Enrollment
361 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloproliferative disorders, leukemia, lymphoma, myelodysplastic syndromes, myelodysplastic/myeloproliferative diseases, nonmalignant neoplasm, unspecified adult solid tumor, protocol specific, unspecified childhood solid tumor, protocol specific